These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34692415)

  • 21. Juvenile-Onset Immunodeficiency Secondary to Anti-Interferon-Gamma Autoantibodies.
    Liew WK; Thoon KC; Chong CY; Tan NWH; Cheng DT; Chan BSW; Ng MSY; Das L; Arkachaisri T; Huang CH; Kuan JL; Chai LYA; Koh MJA
    J Clin Immunol; 2019 Jul; 39(5):512-518. PubMed ID: 31177358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-interferon-γ autoantibody and opportunistic infections: case series and review of the literature.
    Kampitak T; Suwanpimolkul G; Browne S; Suankratay C
    Infection; 2011 Feb; 39(1):65-71. PubMed ID: 21128092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disseminated Mycobacterium avium and recurrent Salmonella group D infection in a patient with autoantibodies to interferon-gamma.
    Chaisathaphol T; Jitmuang A
    Southeast Asian J Trop Med Public Health; 2013 May; 44(3):460-7. PubMed ID: 24050078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disseminated cutaneous Mycobacterium kansasii infection presenting with Rosai-Dorfman disease-like histological features in a patient carrying anti-interferon-γ autoantibodies.
    King YA; Hu CH; Lee YJ; Lin CF; Liu D; Wang KH
    J Dermatol; 2017 Dec; 44(12):1396-1400. PubMed ID: 28836691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disseminated Mycobacterium avium Infection Complicated with Chylous Ascites in a Patient with Neutralizing Autoantibodies to Interferon-γ.
    Yamaba Y; Takakuwa O; Wang Z; Saito M; Kawae D; Yoshihara M; Kunii E; Ito Y; Akita K
    Intern Med; 2020 Dec; 59(24):3195-3200. PubMed ID: 32788530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fatal Mycobacterium colombiense/cytomegalovirus coinfection associated with acquired immunodeficiency due to autoantibodies against interferon gamma: a case report.
    Poulin S; Corbeil C; Nguyen M; St-Denis A; Côté L; Le Deist F; Carignan A
    BMC Infect Dis; 2013 Jan; 13():24. PubMed ID: 23336346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disseminated Mycobacterium haemophilum skeletal disease in a patient with interferon-gamma deficiency.
    Otome O; O'Reilly M; Lim L
    Intern Med J; 2015 Oct; 45(10):1073-6. PubMed ID: 26429217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Daratumumab (Anti-CD38) for Treatment of Disseminated Nontuberculous Mycobacteria in a Patient With Anti-Interferon-γ Autoantibodies.
    Ochoa S; Ding L; Kreuzburg S; Treat J; Holland SM; Zerbe CS
    Clin Infect Dis; 2021 Jun; 72(12):2206-2208. PubMed ID: 32745179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-IFN-gamma autoantibodies in disseminated nontuberculous mycobacterial infections.
    Patel SY; Ding L; Brown MR; Lantz L; Gay T; Cohen S; Martyak LA; Kubak B; Holland SM
    J Immunol; 2005 Oct; 175(7):4769-76. PubMed ID: 16177125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triple infection with Cryptococcus, varicella-zoster virus, and Mycobacterium abscessus in a patient with anti-interferon-gamma autoantibodies: a case report.
    Rujirachun P; Sangwongwanich J; Chayakulkeeree M
    BMC Infect Dis; 2020 Mar; 20(1):232. PubMed ID: 32188404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levels of anti-cytokine antibodies may be elevated in patients with pulmonary disease associated with non-tuberculous mycobacteria.
    Kim K; Waterer G; Thomson R; Yang IA; Nashi N; Tan DB; Price P
    Cytokine; 2014 Apr; 66(2):160-3. PubMed ID: 24508556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subcutaneous injection of interferon gamma therapy could be useful for anti-IFN-γ autoantibody associated disseminated nontuberculous mycobacterial infection.
    Harada M; Furuhashi K; Karayama M; Suzuki Y; Hozumi H; Enomoto N; Fujisawa T; Nakamura Y; Inui N; Suda T
    J Infect Chemother; 2021 Feb; 27(2):373-378. PubMed ID: 33071037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Significance of Interferon-γ Neutralizing Autoantibodies Against Disseminated Nontuberculous Mycobacterial Disease.
    Aoki A; Sakagami T; Yoshizawa K; Shima K; Toyama M; Tanabe Y; Moro H; Aoki N; Watanabe S; Koya T; Hasegawa T; Morimoto K; Kurashima A; Hoshino Y; Trapnell BC; Kikuchi T
    Clin Infect Dis; 2018 Apr; 66(8):1239-1245. PubMed ID: 29126235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disseminated Mycobacterium avium complex infection in a patient carrying autoantibody to interferon-γ.
    Ishii T; Tamura A; Matsui H; Nagai H; Akagawa S; Hebisawa A; Ohta K
    J Infect Chemother; 2013 Dec; 19(6):1152-7. PubMed ID: 23456204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-interferon-gamma autoantibody related disseminated nontuberculous mycobacteriosis with pathological features of immunoglobulin G4-related disease.
    Nagamura N; Imada T
    Immunol Med; 2022 Mar; 45(1):48-53. PubMed ID: 34033731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel assay to detect increased level of neutralizing anti-interferon gamma autoantibodies in non-tuberculous mycobacterial patients.
    Shima K; Sakagami T; Tanabe Y; Aoki N; Moro H; Koya T; Kagamu H; Hasegawa T; Suzuki E; Narita I
    J Infect Chemother; 2014 Jan; 20(1):52-6. PubMed ID: 24462426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disseminated Nontuberculous Mycobacterial Infection in a Patient with Anti-IFN-γ Autoantibodies.
    Tanimizu M; Mizuno K; Hashimoto M
    Acta Med Okayama; 2017 Dec; 71(6):547-552. PubMed ID: 29276230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disseminated Non-tuberculous Mycobacteriosis with a Skull Lesion Controlled by Resection after Exacerbation during Antimicrobial Chemotherapy in a Patient Positive for Anti-IFN-γ-neutralizing Autoantibodies.
    Chubachi K; Taima K; Ishidoya M; Tanaka Y; Kurose A; Tasaka S
    Intern Med; 2024 Jul; 63(14):2053-2057. PubMed ID: 38044155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rituximab Restores IFN-γ-STAT1 Function and Ameliorates Disseminated Mycobacterium avium Infection in a Patient with Anti-Interferon-γ Autoantibody.
    Koizumi Y; Sakagami T; Nishiyama N; Hirai J; Hayashi Y; Asai N; Yamagishi Y; Kato H; Hagihara M; Sakanashi D; Suematsu H; Ogawa K; Mikamo H
    J Clin Immunol; 2017 Oct; 37(7):644-649. PubMed ID: 28779413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional neutralization of anti-IFN-γ autoantibody in patients with nontuberculous mycobacteria infection.
    Krisnawati DI; Liu YC; Lee YJ; Wang YT; Chen CL; Tseng PC; Lin CF
    Sci Rep; 2019 Apr; 9(1):5682. PubMed ID: 30952894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.